z-logo
Premium
Characterization of conantokin Rl ‐A: molecular phylogeny as structure/function study
Author(s) -
Gowd Konkallu H.,
Watkins Maren,
Twede Ver D.,
Bulaj Grzegorz W.,
Olivera Baldomero M.
Publication year - 2010
Publication title -
journal of peptide science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 66
eISSN - 1099-1387
pISSN - 1075-2617
DOI - 10.1002/psc.1249
Subject(s) - phylogenetics , computational biology , characterization (materials science) , function (biology) , chemistry , evolutionary biology , biology , biochemistry , nanotechnology , materials science , gene
A multidisciplinary strategy for discovery of new Conus venom peptides combines molecular genetics and phylogenetics with peptide chemistry and neuropharmacology. Here we describe application of this approach to the conantokin family of conopeptides targeting NMDA receptors. A new conantokin from Conus rolani , Con Rl ‐A, was identified using molecular phylogeny and subsequently synthesized and functionally characterized. Con Rl ‐A is a 24‐residue peptide containing three γ‐carboxyglutamic acid residues with a number of unique sequence features compared to conantokins previously characterized. The HPLC elution of Con Rl ‐A suggested that this peptide exists as two distinct, slowly exchanging conformers. Con Rl ‐A is predominantly helical (estimated helicity of 50%), both in the presence and absence of Ca ++ . The order of potency for blocking the four NMDA receptor subtypes by Con Rl ‐A was NR2B > NR2D > NR2A > NR2C. This peptide has a greater discrimination between NR2B and NR2C than any other ligand reported so far. In summary, Con Rl ‐A is a new member of the conantokin family that expands our understanding of structure/function of this group of peptidic ligands targeted to NMDA receptors. Thus, incorporating phylogeny in the discovery of novel ligands for the given family of ion channels or receptors is an efficient means of exploring the megadiverse group of peptides from the genus Conus . Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here